Profiel
Xiao Lin Wang worked as the VP-Biometrics & Development Operations at Geron Corp.
from 2010 to 2015.
From 2015 to 2018, she held the position of Vice President-Biometrics at Acerta Pharma LLC.
Currently, she is the Executive Vice President-Clinical Development at Revolution Medicines, Inc. starting from 2018.
Dr. Wang holds a doctorate degree from Harvard University, a graduate degree from the University of Washington, and an undergraduate degree from Peking University.
Eerdere bekende functies van Xiao Lin Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01-04-2023 |
| Acerta Pharma LLC | Corporate Officer/Principal | 01-03-2018 |
| GERON CORPORATION | Corporate Officer/Principal | 01-05-2015 |
Opleiding van Xiao Lin Wang
| Harvard University | Doctorate Degree |
| University of Washington | Graduate Degree |
| Peking University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Acerta Pharma LLC |
